PARTICIPATING ORGANISATIONS - 2024 (UPDATING MORE...)
The Maxwell Centre is the centrepiece for industrial engagement with the physical scientists and engineers working on the West Cambridge Science and Technology Campus.
Thermo Fisher Scientific Inc. is an American supplier of analytical instruments, life sciences solutions, specialty diagnostics, laboratory, pharmaceutical and biotechnology services.
CIC is the global leader in driving innovation at scale. Founded in 1999, CIC manages more than 1.5M square feet of workspace, laboratories, and event space across North America, Europe, and Asia. Additionally, CIC develops bespoke programming, builds and enables industry clusters, and provides world-class district consulting—all focused on advancing innovation.
Maxion uses its innovative KnotBody technology in combination with in vitro display technologies to generate therapeutic candidates against ion channels and GPCR proteins.
Lark Optics is a Cambridge University spinout company that provides nanooptical solutions.
ideaSpace provides office space and resources for anyone looking to start a new, high impact company in Cambridge. ideaSpace members and their employees benefit from a stimulating working environment, the ability to share experiences with like-minded start-up founders and gain access to some of the UK’s most successful entrepreneurs and investors.
Domainex is a fully integrated drug discovery service company based near Cambridge, UK serving pharmaceutical, biotechnology, academic and patient foundations globally.
T-Therapeutics is a next-generation T cell receptor (TCR) company spun off from the University of Cambridge. The company was created to harness the power of T cell biology, evolved over millions of years, to create safe and effective treatments for many cancers and autoimmune diseases.
Altos Labs is a biotechnology company focused on restoring cell health and resilience through cell rejuvenation to reverse disease, injury, and the disabilities that can occur throughout life.
Isogenica develops VHH: highly versatile small format antibodies which they use to construct next generation biotherapeutics for the treatment of cancer, inflammation and other serious diseases.
Healx is a mission-driven technology company pioneering the next generation of drug discovery in order to bring novel, effective treatments to rare disease patients around the world.
Arecor is a globally focused biopharmaceutical company that is transforming patient care by bringing innovative medicines to market through the enhancement of existing therapeutic products.
Five Alarm Bio is developing a small molecule approach to boost the body’s defence to aging, based on a new understanding of how the chemical damage associated with age accumulates in cells.
Artios is on a mission to kill cancer by exploiting DNA damage response (DDR) and repair pathways that are leveraged by cancer cells to promote their survival.
Source BioScience, comprised of Source LDPath and Source Genomics, provides industry-leading laboratory services in Genomics and Histopathology, partnering with biotechnology, pharmaceutical, healthcare and academia.
VNC Automotive deliver ingenious connectivity and telematics software for the vehicles of tomorrow. Their solutions enable time spent in-vehicle to be more entertaining and more productive than ever, whilst relentlessly adhering to safety and security protocols.
Sookio is an award-winning digital marketing agency based in Cambridge, UK. Their focus is on content - copywriting, social media, video and design - coupled with expert strategy and training to help businesses become confident from within.
Robotae is a technology design and development consultancy specialising in robotics and mechatronics.
RFcreations is a core team of highly skilled and knowledgeable, professional engineers with decades of experience across the design and development of both RF and digital hardware, embedded, protocol stacks and UI software.
Printed Electronics Ltd is a UK company developing processes and systems for the commercial fabrication of electronic devices and systems using inkjet and digital methods.
Novalia develops technology called PrintedTouch that adds touch activation to printed surfaces, while also enabling wireless connectivity and data capture. Adding touch, connectivity and data to surfaces, Novalia converges both worlds by using tactile printed touch sensors to unlock our childhood desire to discover through touch. Novalia combines sensors from printed conductive ink with silicon micro controllers, then sound or Bluetooth technology to create leading-edge, breakthrough products for brands all over the world.
Mtech Access is a provider of health economics consulting and outcomes research strategy services intended for pharmaceutical companies and the life sciences industry.
Mewburn Ellis LLP is a European intellectual property law firm. It is one of the UK's largest firms of Chartered Patent Attorneys, European Patent Attorneys, European Trade Mark Attorneys and European Design Attorneys.
Health Tech Enterprise specializes in technology advisory and innovation management within the healthcare sector. The company offers a range of services including market research, intellectual property strategy, commercialization planning, health economic evaluations, regulatory compliance guidance, and securing funding for health technology innovators.
F.INSTITUTE is a full service finance boutique for the life sciences, pharma, biotech, deep tech and new energy sector, has recently expanded its portfolio of bookkeeping, tax, and CFO services for growing businesses in the UK market.
CB3 Consulting is a cost management business focused on it's clients, with an engaged, motivated team at the heart of everything it does.
Cambridge Kinetics is situated in the heart of the UK’s high-tech cluster in Cambridge, focused on delivering high-quality software solutions.
Archipelago Technology is a technological consulting firm with an emphasis on accurate measurement and management. It works in the fields of printing, precise manufacturing, medicine, energy, and instrumentation, and it creates solutions to help clients' businesses grow.
NAPP (Not Another Photorealistic Pack) is a free Minecraft resource pack with the objective of answer that question. It’s goal is to recreate with accuracy all the vanilla textures in HD, with a more realistic style but without losing the ‘videogame’ stylized feel.
Cambridge Consultants is a world-class supplier of innovative product development and technology consulting.
CMR Surgical is a global medical devices company dedicated to transforming surgery with Versius®, a next-generation surgical robot. CMR is committed to working with surgeons, surgical teams and hospital partners, to provide an optimal tool to make robotic minimal access surgery universally accessible and affordable.
The mission of Raspberry Pi is to put high-performance, low-cost, general-purpose computing platforms in the hands of enthusiasts and engineers all over the world. Since 2012, they’ve been designing single-board and modular computers, built on the Arm architecture, and running the Linux operating system.
Neuro XR is developing an AI and neuroscience-based heat map platform that helps developers of physical and virtual spaces and products better understand their users and form more sustainable relationships through real-time, accurate and visual feedback analytics
Cambridge Science Centre is a registered educational charity (UK Registered Charity No. 1146349) that creates hands-on exhibits, interactive shows and workshops to get the young learners excited about science. These fun and unique experiences are gained through our schools and community outreach programmes.
CorrosionRADAR is a leading provider of smart corrosion monitoring and analytics solutions for critical industrial asset integrity issues such as corrosion under insulation (CUI). Enabling Digitalisation and Industry 4.0 with its innovations in sensing and predictive analytics, CorrosionRADAR’s solutions monitor and predict risk remotely, allowing businesses to make data-driven decisions in their industrial assets.
Cambridge Cleantech is a leading membership organisation that provides commercial support to companies that are driving the development of goods and services in response to global sustainability challenges. They are a powerful catalyst for change that has brokered hundreds of key business collaborations and helped put sustainable technologies firmly at the heart of the Cambridge Phenomenon.
The Hauser Forum is a new state-of-the-art focal point for entrepreneurship in the East of England. The forum is situated on the University of Cambridge's West Cambridge Research and Development Park which also includes many notable buildings at the forefront of science research,
CamGene Therapeutics is a developer of nanoparticle-based mRNA therapeutic drugs designed for patients who have lost their hearing power. The company's lipid nanoparticle based mRNA technology precisely targets ear cells, enabling doctors to treat the underlying cellular dysfunction which is the root cause of hearing loss.
Serendipity Labs was founded in 2011 with a vision to build a network of inviting, inspirational workplaces, combining state-of-the-art design, technology and security with the highest service level standards to deliver a consistent and peerless workplace experience through company-owned and managed locations in over 30 urban and suburban locations across the country.
Grant Instruments have been designing and manufacturing scientific temperature control and data acquisition technologies, together with lifescience laboratory equipment for over 67 years and are now a market leader.
The University of Cambridge Institute for Sustainability Leadership (CISL) is a globally influential institute developing leadership and solutions for a sustainable economy. For over three decades, CISL has built individual and organisational leadership capacity and capabilities and created industry-leading collaborations, to catalyse change and accelerate the path to a sustainable economy.
PharmEnable, based in Cambridge, UK, is a biopharmaceutical company specializing in discovering small-molecule medicines for targets inaccessible to antibodies. Using their AI-enabled platform, chemSEEK, they identify novel molecules with antibody-like specificity. With a focus on oncology and neurology, PharmEnable develops a pipeline of therapeutics and collaborates on drug discovery in challenging disease areas.
Ignota Labs is an innovative research and development company focused on creating transformative solutions in the fields of biotechnology and bioinformatics. With a multidisciplinary approach and a team of experts in biology, data science, and technology, Ignota Labs is at the forefront of innovation. From drug discovery to genomic analysis, Ignota Labs is dedicated to pushing the boundaries of science and driving positive change in healthcare and beyond.
Neurometry is a pioneering neuroscience company focused on developing advanced technologies for brain monitoring and analysis, with a mission to revolutionize the diagnosis and treatment of neurological disorders. Their neurostimulation and neurofeedback games are specifically designed to target cognitive skills such as memory, attention, and problem-solving, leveraging principles of neuroplasticity to enhance brain function. Incorporating elements of biofeedback, these games provide users with real-time feedback on their brain activity, empowering them to actively engage in their cognitive training. By combining entertainment with scientifically validated brain training methods, Neurometry's games offer a fun and effective way to improve cognitive function and support neurological health, ultimately helping individuals unlock their full cognitive potential.
Granta Park is an inspirational estate which perfectly captures the essence of Cambridge and the life science community. Established for over 20 years, Granta Park offers 120 acres of truly inspirational surroundings, creating a perfect environment for a work-life balance and has a scientific population of over 3,700 people working on the future technologies of the world.
The Cambridge Science Park was established 52 years ago when Trinity College Cambridge embraced the concept that would change the hi-tech sector in Cambridge, the UK and beyond. Trinity owns the freehold of the Cambridge Science Park, which today comprises 150 acres, 1.7 million sq ft of high technology and laboratory buildings. It’s home to 7000 people at over 130 companies, ranging from exciting start-ups to some of the world's leading technology businesses.
The Bradfield Centre offers cutting-edge facilities designed to propel businesses to new heights. Their goal is to attract ambitious entrepreneurs and companies, both local and global, and provide them with scalable, state-of-the-art spaces. Through a collaborative culture, they connect them to investors, partners, mentors, and customers. Their accelerator programs cover diverse business and technical topics, aiming to grow Cambridge-based businesses exponentially.
Anglia Ruskin University is one of the largest universities in the East of England with campuses in Cambridge, Chelmsford and Peterborough as well as ARU London. ARU is an innovative global university with students from 185 countries coming to study with us.
The Babraham Institute performs world-leading research into the biological mechanisms underpinning ageing, development and the maintenance of health. We have three research focuses;
Epigenetics - Studying modifications to DNA that affect gene activity, which helps to explain how our environment and lifestyle can affect our behavior or likelihood of getting diseases.
Immunology - The study of the immune system, which helps to prevent disease in our bodies. Research in this area can lead to improvements in vaccines, combat autoimmune disease, develop tumour immunotherapy or improve the efficiency of organ transplantation.
Signalling - Researching communication within and between the cells in our body, which underpins how cells and organs develop and respond to changes in their environment, vital for maintaining health.
Building on over 200 years of heritage, we are a major UK law firm located in the heart of Cambridge and six other cities across the country. Our office at Botanic House on Hills Road will be hosting 10 science and tech companies who will be waiting to meet and chat with you about their work.
The Babraham Research Campus is considered to be the UK’s leading campus to support early-stage bioscience enterprise and is distinct in its co-location of bioscience companies with the Babraham Institute, a world-renowned research organisation. The Campus provides companies with state-of-the-art laboratory and office space together with access to outstanding scientific facilities in an ideal geographical location at the core of the Cambridge cluster.
Unity Campus is an exciting new urban innovation district in the heart of the Cambridgeshire countryside. Campus owners Howard Group, a Cambridge-based family business with a 50-year track record as a long-term property investor and developer, is transforming the site of a former tannery into a stunning modern workplace.
Founded in 1987, we are a sector-agnostic home for some 80 innovative companies: scaling-up, going international and raising risk capital. The Centre is set in extensive grounds within easy access of central Cambridge and has a popular restaurant and conference suite.
Innovate UK is the UK’s national innovation agency. They support business-led innovation in all sectors, technologies and UK regions. It help businesses grow through the development and commercialisation of new products, processes, and services, supported by an outstanding innovation ecosystem that is agile, inclusive, and easy to navigate.
ET Capital Limited, founded in 1992, is an investor in high-growth technology businesses based in southern England. The firm has raised and managed a series of funds focused on the globally significant cluster of science-based businesses around Cambridge, Oxford and London. Its first two funds, now closed, were backed by HSBC and the European Investment Fund.
At Illumina, our mission is to improve human health by unlocking the power of the genome. By delivering breakthroughs that redefine what's possible in genomics, we empower visionaries around the globe to uncover answers and make life-changing advances.
Enterprise is an area that clearly defines NatWest. As the UK’s biggest bank for business, we understand that SMEs are the lifeblood of the economy and that we have a responsibility to help them build back better. At the heart of our support for entrepreneurs is our comprehensive Accelerator programme including fully funded mentoring, insight and bespoke coaching, specifically designed to meet the needs of business owners who want to grow and scale their business, regardless of geographic location or sector.
The Cambridge Future Tech Venture Builder provides inventors, innovators and founders with the tools and collaboration required to succeed in building a DeepTech company.
We have Future Business Centres in Cambridge and Peterborough that offer flexible workspace, meeting rooms and networking, all within environmentally focused buildings – creating innovation communities for local businesses and social enterprises. Our expert programme team in East London work with local businesses to help them build resilience, grow and create positive impact.
Melbourn Science Park by Bruntwood SciTech offers world class office, laboratory and co-working space across the UK and is home to over 500 science and technology businesses. A 50:50 joint venture between Bruntwood and Legal & General, they create specialist working environments and provide support for businesses to start, scale and innovate. With science and technology ecosystems located in Manchester, Cheshire, Birmingham, Leeds, Liverpool and Glasgow, they acquired Melbourn Science Park, Cambridgeshire, in 2021. Plans have been submitted for a ten-year masterplan to redevelop the site into a globally recognised life science campus where research, innovation and manufacturing come together and change the future of human health. The Park will provide an inclusive place to work and socialise, promoting wellbeing and community for both local residents and businesses on the campus.
TusPark Holdings UK is a science and technology service corporation with an investment arm as a venture capital and private equity group fund. TUS has invested £250M+ in science and technology sector in the UK since 2018 and its investment portfolio spans in the era of life science/healthcare, digital technologies (big data, AI and IoT, etc.), new material, and environmental & new energy, with a unique model of "Incubation + Investment + cross-border M&As".
The Cambridge Judge Entrepreneurship Centre is where entrepreneurship gets real. It is where ground-breaking research and excellence in teaching combine to create global impact and enable entrepreneurs to turn ideas or innovations into real commercial applications and sustainable businesses. The Entrepreneurship Centre supports entrepreneurs and innovators at different stages from aspiration to venture creation and startup development, through to expansion and growth. We offer multiple entry points to resources, programmes and networks allowing individuals to structure and customise a personal journey directly relevant to them and their ventures.
Alchemab has developed a highly differentiated platform which enables the identification of novel drug targets and therapeutics by analysis of patient antibody repertoires. The platform uses well-defined patient samples, deep B cell sequencing, and computational analysis to identify convergent protective antibody responses among individuals that are susceptible but resilient to specific diseases.
Form the Future CIC connects young people to a world of career possibilities, inspires them to dream big and empowers them to fulfil their full potential.
Astex has built a rich product portfolio with multiple drugs in clinical development. Our research and development teams utilize our cutting edge technology platform in the relentless pursuit of innovative solutions that address the extensive and complex challenges in oncology and diseases of the CNS.
bit.bio is a synthetic biology company providing human cells for research, drug discovery and cell therapy. The company applies a patented safe harbour gene-targeting approach (opti-ox™; Pawlowski 2017) to inducibly express transcription factor combinations that reprogram human induced pluripotent stem cells (iPSCs) into highly defined and mature human cell types.
The Triple Chasm Model® is a unique new approach to drive successful commercialisation of innovation, delivering quantifiable impact. Underpinned by data from more than 3,000 scale-up companies around the globe.
Lives can be transformed when the strength of academia and business combine. As a biomedical institute, the Milner Therapeutics Institute acts as a catalyst and a driver, forming dynamic partnerships to unlock the power of emerging discoveries.
The Milner encompasses both a research institute and a global outreach programme, which aims to transform pioneering science into therapies. The Institute is also home to the Frame Shift Bio-incubator, which provides space for start-ups and SMEs.
Part of the University of Cambridge, Cambridge Enterprise is responsible for supporting the translation of University research to create globally leading economic and social impact. We facilitate knowledge transfer by helping innovators, experts, and entrepreneurs to use commercial avenues to develop their ideas and expertise for the benefit of society, the economy, themselves, and the University.
Hear Glue Ear is an app designed for children aged 2-6 who are experiencing hearing loss due to glue ear. The app is available to download free of charge from the Apple and Android App Stores.
Crescendo Biologics Limited is a private, clinical-stage immuno-oncology company developing novel, targeted T cell enhancing Humabody® therapeutics. The lead programme, CB307, is a first-in-class PSMA x CD137 (4-1BB) bispecific molecule. Behind the lead programme, there is a pipeline of other first or best in class CD137 (4-1BB) bispecifics for the treatment of cancers, targeting MSLN, 5T4 and ROR1.
BugBiome is a biotech start-up that specializes in revolutionizing pest control through cutting-edge microbial science. The company focuses on the development of eco-friendly bio-repellents, ensuring effectiveness while prioritizing safety for humans, animals, and the environment. BugBiome's approach to sustainable pest management aims to contribute significantly to a healthier planet.
Insmed is a global biopharmaceutical company on a mission to transform the lives of patients with serious and rare diseases. The Company is dedicated to developing and bringing to market therapies that make a real difference in patients’ lives, while striving to understand and enhance the entire patient experience, from diagnosis and treatment to everyday living.
New Path Molecular specialises in the chemical synthesis of complex functional molecules using the cutting edge techniques, methods and instrumentation developed in the laboratories of Prof Steve Ley at the University of Cambridge. Our processes and molecules are being used to validate biological processes and produce products globally.
Mission Street was founded in 2017 as an independent investor, developer and operator of Science and Innovation real estate. The company has since established itself as an industry leader working in conjunction with a highly experienced Advisory Board who bring invaluable insight and expertise from the perspective of our customers.
Carbon-13 (13C) is a natural, stable isotope of carbon with a nucleus containing six protons and seven neutrons. They are the venture builder for the climate emergency, with a mission to reduce CO2e emissions by 400m tonnes through scalable climate tech ventures
Ethicronics main activity is hardware-enabled cybersecurity fighting against counterfeit and compromised electronics. Their first unique selling point is certifying your hardware is the one designed, at scale. Their SaaS solution provides hardware integrity certificates for market segments such as defence, security, transport, communication, finance and IoT.
Neurolentech was founded in late 2020 as a spin-out from IST Austria to identify new treatments for neurodevelopmental disorders. They use the latest scientific laboratory techniques to develop patient-derived neuronal cell models that give us insights into the molecular mechanisms of disease.
Deep Mirror is a team of leading experts at the interface of biology, physics, and machine learning, we are committed to bold innovation and on a clear mission: to elevate learning in the Life Sciences and power innovation in the century of biology.
Exonate is a biopharmaceutical company focused on the discovery and development of small molecule drugs that modulate alternative mRNA splicing to address diseases of high unmet medical need.
Kuano is focused on the discovery of new drugs with a novel AI and quantum simulation approach to finding better transition state-like inhibitors to overcome resistance by mutation. Kuano revolutionized this approach, once time-consuming and expensive, making it more rapid, cost-effective, and applicable to almost every therapeutic field.
Informetis creates value out of energy data. Their four technology pillars: Metis Device, Metis Cloud, Metis Engine and Metis App. Creating value out of energy data by utilising these unique tools, we call it Energy Informetis.
BioBeat connects entrepreneurs with biotech leaders. The annual summit challenges current thinking and the report selects 50 women trend setters.
At the Wellcome Genome Campus we undertake genome and biodata research. We provide bioinformatics services to the world and we deliver vital training in genomics and biodata to scientists and clinicians. We are at the interface of research and industry translating science into tangible societal benefits.
Nuclera: Rapid protein prototyping — it’s what we do. It’s what we deliver. Rapid protein prototyping draws a straight line from theory to reality, allowing scientists to test hypotheses more efficiently. We understand that scientists need access to protein prototyping on their own bench, on their own terms.
PhoreMost has developed a next-generation phenotypic screening platform called SITESEEKER® which can discern the best new targets for future therapies and, crucially, how to drug them. This has the potential to significantly increase the diversity of novel therapeutics for cancers and other disease of unmet need.
Enhanc3DGenomics' mission is to unlock the full potential of the human genome’s 3D organisation for target and biomarker discovery. They have expertise in developing an unparalleled platform integrating proprietary molecular biology technologies with machine learning to maximise the commercial potential of 3D genomics.
Creasallis was founded in 2021 by Zahra Jawad. It was created after the realization that innovation is limited in the pharmaceutical industry as the product pipeline dominates in this environment, and competition for resourcing and facilities is high. To make truly innovative drugs, start ups are needed to create that safe space to explore novel solutions.
We founded Kalium Health with the aim of providing real-world electrolyte data to transform the management of cardiorenal diseases. We have a world-class team, led by science and dedicated to medical product development. Our clinical focus is on kidney disease, heart disease and related chronic conditions where the cost of care is disproportionately high and the opportunity to improve health outcomes for a large population is great.
The Cambridge Crystallographic Data Centre (CCDC) are world-leading experts in structural chemistry data, software, and knowledge for materials and life sciences research and development.
CCDC data, software, and services are trusted by academic and industrial institutions around the world with tens of thousands of active users from top 10 pharma to leading research institutions.
Cambridge Network is a membership organisation bringing people together through networking, learning, recruitment and events. We connect and support businesses, sparking collaboration within our vibrant network of over a thousand members.
Start Codon is a venture capital investor and venture builder based in Cambridge, England. We support aspiring entrepreneurs to spin out and/or help in the development and commercialisation of their disruptive innovations. In doing so, we aim to help them craft their vision into thriving companies that improve people’s lives and address unmet needs.
o2h co-work labs operates the mill scitech park in Hauxton, Cambridge, a place for entrepreneurs, scientists, techies & dreamers. Supported by high specification labs to create a genuinely unique environment for creativity and innovation to thrive.